ScoreWhy is GPT Healthcare Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.40% of over the last 5 years
2
Negative results in Sep 25
- PAT(Latest six months) At Rs 18.28 cr has Grown at -26.23%
- ROCE(HY) Lowest at 18.76%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 1.87 cr
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -4.62% over the previous quarter and collectively hold 9.66% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Below par performance in long term as well as near term
- Along with generating -23.39% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to GPT Healthcare should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is GPT Healthcare for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
GPT Healthcare
-1.11%
-0.72
32.66%
Sensex
-4.95%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.66%
EBIT Growth (5y)
-9.60%
EBIT to Interest (avg)
11.77
Debt to EBITDA (avg)
1.44
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.29
Tax Ratio
22.97%
Dividend Payout Ratio
41.09%
Pledged Shares
0
Institutional Holding
9.65%
ROCE (avg)
23.21%
ROE (avg)
20.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
60
Price to Book Value
4.73
EV to EBIT
22.16
EV to EBITDA
15.03
EV to Capital Employed
3.99
EV to Sales
2.68
PEG Ratio
NA
Dividend Yield
1.71%
ROCE (Latest)
18.74%
ROE (Latest)
16.64%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NET SALES(Q)
Highest at Rs 120.16 cr
-24What is not working for the Company
INTEREST(Latest six months)
At Rs 4.42 cr has Grown at 66.79%
OPERATING PROFIT TO INTEREST(Q)
Lowest at 9.16 times
ROCE(HY)
Lowest at 18.76%
PBT LESS OI(Q)
At Rs 11.34 cr has Fallen at -15.7% (vs previous 4Q average
PAT(Q)
At Rs 9.37 cr has Fallen at -13.7% (vs previous 4Q average
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 1.87 cr
Loading Valuation Snapshot...
Here's what is working for GPT Healthcare
Net Sales - Quarterly
Highest at Rs 120.16 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for GPT Healthcare
Operating Profit to Interest - Quarterly
Lowest at 9.16 times and Fallen
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest - Latest six months
At Rs 4.42 cr has Grown at 66.79%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 11.34 cr has Fallen at -15.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 13.46 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 9.37 cr has Fallen at -13.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 10.86 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.87 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
